Wordt geladen...
Telaprevir/boceprevir era: From bench to bed and back
Hepatitis C virus (HCV) infects approximately 200 million people worldwide. Interferon-based therapies have dominated over the past two decades. However, the overall response rates remain suboptimal. Thanks to the tremendous effort from both academia and industry, two serine protease inhibitors tela...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Co., Limited
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501765/ https://ncbi.nlm.nih.gov/pubmed/23180937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i43.6183 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|